Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012
Author:
Affiliation:
1. Department of Haematology; Oxford University Hospitals NHS Trust; Oxford
2. Department of Haematology; Royal Victoria Infirmary; Newcastle Upon Tyne
3. Department of Haematology; Guy's and St. Thomas' NHS Foundation; London, UK
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09107.x/fullpdf
Reference75 articles.
1. The outcome of allo-HSCT for 92 patients with myelofibrosis in the Nordic countries;Abelsson;Bone Marrow Transplantation,2011
2. Impact of JAK2V617F mutation status, allele burden, and clearance after allogeneic stem cell transplantation for myelofibrosis;Alchalby;Blood,2010a
3. Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT;Alchalby;Bone Marrow Transplantation,2010b
4. Allogeneic hemopoietic SCT for patients with primary myelofibrosis: a predictive transplant score based on transfusion requirement, spleen size and donor type;Bacigalupo;Bone Marrow Transplantation,2010
5. Outcome of transplantation for myelofibrosis;Ballen;Biology of Blood and Marrow Transplantation,2010
Cited by 45 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Promise: Investigation into the Combination of a Potent Beti with Ruxolitinib in Patients with High or Intermediate-2 Risk Myelofibrosis Not Receiving an Adequate Response with Ruxolitinib Alone;Blood;2023-11-28
2. The 2020 revision of the guidelines for the management of myeloproliferative neoplasms;The Korean Journal of Internal Medicine;2021-01-01
3. HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis;Therapeutic Advances in Hematology;2020-01
4. Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes;PLOS ONE;2019-09-30
5. Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis;European Journal of Haematology;2018-07-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3